Board

Göran Nordlund
Chairman of the board Since 2016

Selected experience: Entrepreneur, private investor and professional board member with significant experience helping startups become well-established companies, including Opus, Hexatronic and Transtema.

Shareholding in CELLINK:
B-stock: 724 808
Ownership: 8,7%
Voting right: 6,2%

Independent in relation to the Company and its management and in relation to major shareholders.

LinkedIn

Erik Gatenholm
Board Member Since 2016

Selected experience: Erik has a background in business management, an MBA from Gothenburg University and documented success in biotechnology entrepreneurship. His honors include Young Entrepreneur of the Year and Innovator of the Year, and he has been listed in Shortcut Magazine’s 100 Under 40 and prestigious Forbes 30 Under 30.

Shareholding in CELLINK:
A-stock: 207 031
B-stock: 2 507 009
Ownership: 32,6%
Voting right: 39,1%

Not Independent in relation to the Company and its management nor in relation to major shareholders.

LinkedIn

Artur Aira
Board Member Since 2017

Selected experience: Medical tech engineer and MBA by training. Prior to his role as Executive Vice President at AddLife, various leadership roles at Organon Teknika, bioMerieux and AddTech Life Science

Shareholding in CELLINK:
Options: 20 000

Independent in relation to the Company and its management and in relation to major shareholders.

LinkedIn

Carsten Browall
Board Member Since 2018

Selected experience: Extensive experience of the medical device and healthcare sectors in senior positions in fast-growing companies such as Mölnlycke, Nobel Biocare, Capio, Vitrolife and Unfors RaySafe.

Shareholding in CELLINK:
Options: 20 000

Independent in relation to the Company and its management and in relation to major shareholders.

Ingela Hallberg
Board Member Since 2017

Selected experience: Doctor by training and after several years of working as physician, she has spent +20 years in leadership roles for various pharma industry leaders such as Bayer Healthcare, Lundbeck, Quintiles and Merck.

Shareholding in CELLINK:
Options: 20 000

Independent in relation to the Company and its management and in relation to major shareholders.

LinkedIn

Bengt Sjöholm
Board Member Since 2016

Selected experience: CEO of several Swedish companies, including Tylö, where he was CEO between 2004 and 2009. During the 1990s, Sjöholm was acting as CEO of a subsidiary of Getinge.

Shareholding in CELLINK:
B-stock: 47 069
Options: 20 000
Ownership: 0,56%
Voting right: 0,4%

Independent in relation to the Company and its management and in relation to major shareholders.

LinkedIn